- Home
- PBYI vs BRY Comparison
PBYI vs BRY Comparison
Compare PBYI & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- BRY
- Stock Information
- Founded
- PBYI 2010
- BRY 1909
- Country
- PBYI United States
- BRY United States
- Employees
- PBYI N/A
- BRY N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- BRY Oil & Gas Production
- Sector
- PBYI Health Care
- BRY Energy
- Exchange
- PBYI Nasdaq
- BRY Nasdaq
- Market Cap
- PBYI 171.7M
- BRY 186.1M
- IPO Year
- PBYI N/A
- BRY N/A
- Fundamental
- Price
- PBYI $3.28
- BRY $3.00
- Analyst Decision
- PBYI Strong Buy
- BRY Buy
- Analyst Count
- PBYI 1
- BRY 2
- Target Price
- PBYI $7.00
- BRY $4.00
- AVG Volume (30 Days)
- PBYI 351.2K
- BRY 954.2K
- Earning Date
- PBYI 08-07-2025
- BRY 08-06-2025
- Dividend Yield
- PBYI N/A
- BRY 4.00%
- EPS Growth
- PBYI 143.51
- BRY N/A
- EPS
- PBYI 0.77
- BRY N/A
- Revenue
- PBYI $232,709,000.00
- BRY $753,737,000.00
- Revenue This Year
- PBYI N/A
- BRY N/A
- Revenue Next Year
- PBYI N/A
- BRY $1.01
- P/E Ratio
- PBYI $4.25
- BRY N/A
- Revenue Growth
- PBYI 2.68
- BRY N/A
- 52 Week Low
- PBYI $2.23
- BRY $2.11
- 52 Week High
- PBYI $4.13
- BRY $6.95
- Technical
- Relative Strength Index (RSI)
- PBYI 40.98
- BRY 48.06
- Support Level
- PBYI $3.34
- BRY $3.03
- Resistance Level
- PBYI $3.55
- BRY $3.23
- Average True Range (ATR)
- PBYI 0.13
- BRY 0.16
- MACD
- PBYI -0.02
- BRY -0.02
- Stochastic Oscillator
- PBYI 11.11
- BRY 8.11
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.